BEIJING , March 26, 2025 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Total revenues were RMB859.2 million (US$117.7 million) in the fourth quarter of 2024, compared with RMB1,138.3 million in the same period of 2023.

image for news Zhihu Inc. Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

Constellation Energy: Price Drop And Robust Results Make It Attractive — Positive

CEG   Seeking Alpha — March 26, 2025

Constellation Energy Group's stock dropped 18% since October on broader concerns around nuclear energy's expected growth, despite strong Q4 and full-year 2024 results, with EPS exceeding expectations by 2.7%. There's much going for CEG, though. The company's 2025 guidance suggests a 6.7% EPS increase, but past trends indicate potential for a higher rise, possibly up to 23.1%. Market multiples are also attractive now, with forward P/E at 23.6x, down from 32.9x in October 2024, reflecting improved valuation.

image for news Constellation Energy: Price Drop And Robust Results Make It Attractive

Costco Stock Sell-Off: Time to Buy the Dip? — Negative

COST   The Motley Fool — March 26, 2025

After surging to a 52-week high of about $1,078 earlier this year, shares of membership-based retailer Costco Wholesale (COST 0.39%) took a huge hit. On the surface, the stock declined because the company reported worse-than-expected fiscal Q2 earnings per share and because of the higher costs Costco could face from tariffs.

image for news Costco Stock Sell-Off: Time to Buy the Dip?

This Simple Industrials ETF Could Turn $1,000 a Month Into $612,000 — Negative

PHO   The Motley Fool — March 26, 2025

Over the past few months, concerns regarding unpredictable tariffs, sticky inflation, and elevated interest rates drove many investors away from macro-sensitive industrial stocks. However, many water stocks bucked that sectorwide downturn.

image for news This Simple Industrials ETF Could Turn $1,000 a Month Into $612,000

BEIJING , March 26, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a China-based IT company, today announced its unaudited consolidated financial results for the quarter and fiscal year ended December 31, 2024. Management Commentary Mr.

image for news Cheetah Mobile Announces Fourth Quarter and Fiscal Year 2024 Unaudited Consolidated Financial Results

Super Group: The Bet's Still On — Neutral

SGHC   Seeking Alpha — March 26, 2025

Super Group reported exceptional Q4 growth, driven by growth in many African markets and Canada, among other markets. Underlying active user growth was also solid. The company is driving operating leverage in maturing markets, while still continuing to rapidly invest in marketing to create a loyal user base. The iGaming business in the US remains weak, and is still guided to be highly unprofitable in 2025 despite noteworthy growth. The total impact on earnings is still moderate.

image for news Super Group: The Bet's Still On

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma, a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has accepted a marketing application for AVT23, a proposed biosimilar to Xolair® (omalizumab), a biologic indicated for treatment of severe persistent allergic asthma and chronic rhinosinusitis with nasal polyps. Global sales of Xolair in 2024 were …

image for news UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)

It's been a rough period for investors in commodity chemical companies. Dow Inc. (DOW -2.63%) and its peer LyondellBasell have seen their stock prices collapse to four-year lows -- with both stocks down over 29% in the last year.

image for news This 7.7%-Yielding Dividend Stock Has Maintained Its Payment for 24 Quarters in a Row. Can That Streak Continue in 2025?

REYKJAVIK, Iceland, PISCATAWAY, N.J. and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma, a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has accepted a marketing application for AVT23, a proposed biosimilar to Xolair® (omalizumab), a biologic indicated for treatment of severe persistent allergic asthma and …

image for news UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)

Tesla hit as Canada suspends EV rebate payments following Trump tariff slap — Negative

TSLA   Proactive Investors — March 26, 2025

Canada has suspended all electric vehicle rebate payments to Tesla Inc (NASDAQ:TSLA) and barred the company from future federal EV incentive programmes, citing concerns over US trade actions. Transport Minister Chrystia Freeland said no funds would be released until each claim is individually verified.

image for news Tesla hit as Canada suspends EV rebate payments following Trump tariff slap

Does ExxonMobil Have the Fuel to Grow Into a $1 Trillion Company? — Neutral

XOM   The Motley Fool — March 26, 2025

ExxonMobil (XOM 0.64%) is the 800-pound gorilla in the oil patch. The energy giant currently has a market cap of more than $500 billion.

image for news Does ExxonMobil Have the Fuel to Grow Into a $1 Trillion Company?

2 Great Growth Stocks Down 64% and 22% to Buy Right Now — Positive

FLNC  NVT   The Motley Fool — March 26, 2025

Disconcerting as the latest market downturn may be, savvy investors know that it's times like these when it's critical to remember that investing is a marathon. Instead of panicking, it's best to steady your nerves and be mindful of the fact that enduring market corrections is table stakes for successful long-term investing.

image for news 2 Great Growth Stocks Down 64% and 22% to Buy Right Now

IonQ: Building A Unique Quantum Edge — Positive

IONQ   Seeking Alpha — March 26, 2025

IonQ's unique trapped-ion technology and strategic partnerships drive strong growth, making shares a strong buy despite recent selloff. New CEO de Masi's focus on commercialization and scaling, along with key acquisitions, enhances IonQ's market position. IonQ's robust patent portfolio and government contracts provide a significant competitive edge in the growing quantum computing market.

image for news IonQ: Building A Unique Quantum Edge

The Smartest Trillion-Dollar Stock to Buy With $1,000 and Hold Forever — Positive

BRK-A  BRK-B   The Motley Fool — March 26, 2025

Few companies have achieved a market cap of $1 trillion. All those who have are leaders in their respective industries and generally produce market-beating returns.

image for news The Smartest Trillion-Dollar Stock to Buy With $1,000 and Hold Forever

Nu Holdings: A Cash Cow In The Making — Positive

NU   Seeking Alpha — March 26, 2025

A weakening Brazilian Real has paused the positive momentum of Nu Holdings. Nonetheless, Nu keeps performing excellently by growing customers, revenue, and profit margins. The valuation looks attractive considering the growth trajectory that's ahead with a PEG ratio at 0.3x.

image for news Nu Holdings: A Cash Cow In The Making

Better Buy: Boeing vs. Lockheed Martin — Positive

BA  LMT   The Motley Fool — March 26, 2025

On March 21, Boeing (BA 0.99%) stock closed 3.1% higher while Lockheed Martin (LMT 1.69%) tumbled 5.8%. The movements resulted from Boeing winning a contract from the Department of Defense for its new warfighter aircraft program -- a contract that Lockheed was the favorite to win.

image for news Better Buy: Boeing vs. Lockheed Martin

1 Growth Stock Down 70% to Buy Right Now — Neutral

CCL   The Motley Fool — March 26, 2025

The travel sector is generally considered one of the most sensitive to macroeconomic conditions.

image for news 1 Growth Stock Down 70% to Buy Right Now

Amazon Grabs 16.2% of Clothing Sales, Leaving Walmart Behind — Positive

AMZN  WMT   PYMNTS — March 26, 2025

While the narrative of Amazon's ascendance in discretionary spending and Walmart's grip on grocery sales dominates the retail conversation, a closer examination of the latest PYMNTS Intelligence report, “Tale of Two Shoppers: Amazon for Discretionary Spending, Walmart for Groceries and Basics,” reveals nuanced shifts in consumer behavior and market share that hold implications for both

image for news Amazon Grabs 16.2% of Clothing Sales, Leaving Walmart Behind

Press Release Deutsches Forschungsnetz selects Nokia to accelerate scientific research with a high-capacity green IP network IP network upgrade allows Deutsches Forschungsnetz e.V. (DFN) to provide seamless access to critical resources and facilitate faster and more efficient collaboration.

image for news Deutsches Forschungsnetz selects Nokia to accelerate scientific research with a high-capacity green IP network

The Best-Performing Vanguard Index Fund of 2025 Is Crushing the S&P 500 — Neutral

VGK   The Motley Fool — March 26, 2025

The S&P 500 (^GSPC 0.16%) has fallen 2% year to date as tariffs imposed by the Trump administration have led to economic uncertainty and even recession fears in the U.S. However, apart from duties on steel and aluminum imports, Europe has so far been excluded from the burgeoning trade war.

image for news The Best-Performing Vanguard Index Fund of 2025 Is Crushing the S&P 500